We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 548

Is Use of a Mark for Services Also Use on Goods Sold?
  • Bereskin & Parr LLP
  • Canada
  • November 29 2016

Litigation results are never fully predictable. That point is brought home clearly by a recent decision of the Federal Court in Heather Ruth McDowell


Good, Better, Best: The Importance of Carefully Describing Goods and Services
  • Bereskin & Parr LLP
  • Canada
  • November 23 2016

The recent decision of the Opposition Board in Gowling Lafleur Henderson LLP v. Banks DIH Ltd highlights the importance of carefully describing


We Promise that it is Still Worthwhile to File Pharma Patents in Canada
  • Bereskin & Parr LLP
  • Canada
  • November 10 2016

The “promise doctrine” is getting a lot of press in the pharma industry. We know that some big pharma companies are ticked off, for example, from Eli


Trademarks and Geographic Place Names CIPO Updates its Practice
  • Bereskin & Parr LLP
  • Canada
  • November 9 2016

On November 9, 2016, the Canadian Intellectual Property Office (CIPO) issued a Practice Notice to clarify its position with respect to trademarks that


7 Things Brand Owners Should Know About CETA and Bill C-30
  • Bereskin & Parr LLP
  • Canada, European Union
  • November 7 2016

On October 30, 2016, Canada and the European Union officially signed the Comprehensive Economic and Trade Agreement (CETA). Bill C-30, the CETA


New Signage Law in Québec - Brand Owners: Get Ready to Add French to your Signage
  • Bereskin & Parr LLP
  • Canada
  • November 4 2016

In a press release yesterday, the Québec Government announced that the proposed amendments to the Regulations under the Charter of the French


Canadian Patent Term Extension - Bill is in the House
  • Bereskin & Parr LLP
  • Canada, European Union
  • November 2 2016

Canada and Europe finally signed off on the Comprehensive Economic and Trade Agreement ("CETA"). Its most significant aspect for the pharma industry


Canada’s Drug Linkage Regulations Finally Grow Up - Becoming a Full Action
  • Bereskin & Parr LLP
  • Canada
  • November 2 2016

Canada is taking steps to streamline drug patent owners' ability to enforce their patents. These steps should reduce the multiplicity of litigation


Canada: Judicial treatment of iconic marks
  • Bereskin & Parr LLP
  • Canada
  • November 1 2016

Although famous marks are not specifically protected by statutory provisions in Canada, protection is available, provided that owners can prove the


“Best” be careful - Rare injunction ordered to stop Cogeco advertising the “best Internet experience in your neighbourhood” - 6 reasons this case is noteworthy
  • Bereskin & Parr LLP
  • Canada
  • October 31 2016

Last August, as part of a rebrand, Cogeco renamed its Internet packages “UltraFibre” and implemented a new homepage for its website, which included